Recombinant multi-species CASPR/CNTNAP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CASPR/CNTNAP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The gene product was initially identified as a 190-kD protein associated with the contactin-PTPRZ1 complex. The 1,384-amino acid protein, also designated p190 or CASPR for 'contactin-associated protein,' includes an extracellular domain with several putative protein-protein interaction domains, a putative transmembrane domain, and a 74-amino acid cytoplasmic domain. Northern blot analysis showed that the gene is transcribed predominantly in brain as a transcript of 6.2 kb, with weak expression in several other tissues tested. The architecture of its extracellular domain is similar to that of neurexins, and this protein may be the signaling subunit of contactin, enabling recruitment and activation of intracellular signaling pathways in neurons. [provided by RefSeq, Jan 2009]
The Alternative Names of target: CASPR, CNTNAP1,Contactin-associated protein 1,Caspr, Caspr1,Neurexin IV, Neurexin-4, p190,CHN3,P190,CASPR,NRXN4,CNTNAP

Target products collectionGo to CASPR/CNTNAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0586-Ab-1/ GM-Tg-hg-IP0586-Ab-2 Human CASPR/CNTNAP1 protein Human
GM-Tg-rg-IP0586-Ab-1/ GM-Tg-rg-IP0586-Ab-2 Rat CASPR/CNTNAP1 protein Rat
GM-Tg-mg-IP0586-Ab-1/ GM-Tg-mg-IP0586-Ab-2 Mouse CASPR/CNTNAP1 protein Mouse
GM-Tg-cynog-IP0586-Ab-1/ GM-Tg-cynog-IP0586-Ab-2 Cynomolgus/Rhesus macaque CASPR/CNTNAP1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0586-Ab-1/ GM-Tg-felg-IP0586-Ab-2 Feline CASPR/CNTNAP1 protein Feline
GM-Tg-cang-IP0586-Ab-1/ GM-Tg-cang-IP0586-Ab-2 Canine CASPR/CNTNAP1 protein Canine
GM-Tg-bovg-IP0586-Ab-1/ GM-Tg-bovg-IP0586-Ab-2 Bovine CASPR/CNTNAP1 protein Bovine
GM-Tg-equg-IP0586-Ab-1/ GM-Tg-equg-IP0586-Ab-2 Equine CASPR/CNTNAP1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0586-Ab-1/ GM-Tg-hg-IP0586-Ab-2; GM-Tg-rg-IP0586-Ab-1/ GM-Tg-rg-IP0586-Ab-2;
GM-Tg-mg-IP0586-Ab-1/ GM-Tg-mg-IP0586-Ab-2; GM-Tg-cynog-IP0586-Ab-1/ GM-Tg-cynog-IP0586-Ab-2;
GM-Tg-felg-IP0586-Ab-1/ GM-Tg-felg-IP0586-Ab-2; GM-Tg-cang-IP0586-Ab-1/ GM-Tg-cang-IP0586-Ab-2;
GM-Tg-bovg-IP0586-Ab-1/ GM-Tg-bovg-IP0586-Ab-2; GM-Tg-equg-IP0586-Ab-1/ GM-Tg-equg-IP0586-Ab-2
Products Name CASPR/CNTNAP1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CASPR/CNTNAP1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CASPR/CNTNAP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.